Seeing Is Believing
Currently out of the existing stock ratings of Kevin Caliendo, 157 are a BUY (49.06%), 11 are a SELL (3.44%), 152 are a HOLD (47.5%).
Analyst Kevin Caliendo, currently employed at UBS, carries an average stock price target met ratio of 64.15% that have a potential upside of 17.98% achieved within 252 days.
Kevin Caliendo’s has documented 626 price targets and ratings displayed on 35 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on PINC, Premier at 24-Sep-2025.
Analyst best performing recommendations are on AGTI (AGILITI).
The best stock recommendation documented was for CVS (CVS HEALTH CORP) at 2/10/2025. The price target of $59 was fulfilled within 2 days with a profit of $5.84 (10.99%) receiving and performance score of 54.93.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$215
$40.04 (22.89%)
$187
2 years 2 months 8 days ago
(07-Aug-2023)
13/14 (92.86%)
$28.91 (15.54%)
633
Hold
$190
$15.04 (8.60%)
$176
2 years 2 months 12 days ago
(03-Aug-2023)
8/8 (100%)
$-0.86 (-0.45%)
433
Buy
$220
$45.04 (25.74%)
$213
2 years 2 months 12 days ago
(03-Aug-2023)
11/17 (64.71%)
$29.14 (15.27%)
326
Buy
$215
$40.04 (22.89%)
$200
2 years 2 months 12 days ago
(03-Aug-2023)
6/8 (75%)
$24.14 (12.65%)
220
Buy
$225
$50.04 (28.60%)
$184
2 years 2 months 14 days ago
(01-Aug-2023)
11/12 (91.67%)
$36.39 (19.29%)
557
Which stock is Kevin Caliendo is most bullish on?
Which stock is Kevin Caliendo is most reserved on?
What Year was the first public recommendation made by Kevin Caliendo?